Rx · Prescription onlyDissolved under the tongue
BIEST 0.1 mg
Menopause, stronger dose.
Your plan
How many tablets per month?
You'll receive 30 tablets per month. $119 billed monthly. Cancel anytime.
- Medication, clinician care and dose adjustments, all in one price.
- ~30-day supply. Your clinician sets your exact dose, so yours may vary; your refill arrives as you finish the last one.
A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.
FDA status: Compounded medication, not FDA-approved.
What it's for
Who it's for
Women whose hot flashes were not controlled on the 0.05 mg tablet.
How it's different
The same 20:80 blend at double the dose.
How it works
BIEST 0.1 mg is the same formulation as BIEST 0.05 mg—estriol and estradiol in a 20:80 bioidentical ratio—but at a double dose. This strength is chosen for patients with more bothersome symptoms or those who do not achieve full relief on 0.05 mg. Both doses dissolve under the tongue and are designed for patients who prefer a compounded bioidentical approach and wish to avoid injections. The safety considerations remain identical to all estrogen therapy.
How to use it and what arrives
30 tablets · lasts 1 month
0.1 mg
- How
- Dissolved under the tongue
- How often
- Once a day
Good to know
Give a dose change four to six weeks before judging it.
What the research shows
Biest is a compounded mix of estriol and estradiol, usually in an 80:20 or 50:50 ratio. It is not FDA-approved, and no outcome trial has tested it; the evidence is pharmacology and a few small studies.
Outcome trials
No outcome trials
No randomized trial has tested Biest against heart, bone or cancer outcomes, or against symptom relief. The 2020 National Academies review judged the evidence for compounded bioidentical hormones insufficient, and found most marketing claims unsupported by well-controlled studies.
National Academies, The Clinical Utility of Compounded Bioidentical Hormone Therapy, 2020Blood levels
Less estrogen than a patch
In a Mayo Clinic randomized trial of 40 postmenopausal women over 16 days, Bi-est cream at the lower doses gave much lower estradiol exposure than a standard estradiol patch with micronized progesterone. The study measured blood levels only, not symptoms or safety.
Bioidentical compounded hormones: a pharmacokinetic evaluation in a randomized clinical trial, Maturitas 2013Estriol part
Limited, mixed evidence
The same National Academies review found limited, mixed-quality evidence that estriol may help some menopausal symptoms, and insufficient evidence about its long-term safety.
National Academies, 2020
Compounded Biest is not the product studied in any trial. The idea that the body needs a particular estrogen ratio is not tested in outcome studies. The known risks of estrogen apply to Biest as well.
What this does not say
- No outcome trial exists for Biest; the blood-level study says nothing about symptoms or safety.
- Compounded doses are not standardized, so the amount in each capsule or cream can vary.
- The trials of estrogen cited elsewhere on this page used other products.
Sources
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022
- Compounded bioidentical hormone therapy: new recommendations from the 2020 National Academies of Sciences, Engineering, and Medicine. Menopause, 2021
- Compounded Bioidentical Hormone Therapy: The National Academies Weigh In. JAMA Intern Med, 2021
Safety
FDA status: Compounded medication, not FDA-approved.
Side effects and precautions
- BIEST is a prescription hormone combination with real benefits and real risks, which is why a clinician reviews your history first.
- Common effects include breast tenderness, bloating, nausea, headache, spotting or breakthrough bleeding, and, on skin, redness or irritation.
- Estrogen therapy increases the risk of blood clots, stroke, gallbladder disease, and, when used with a uterus, must be paired with a progestogen to protect the uterine lining.
- Smoking raises clot risk further.
- Estriol, even at 20% of BIEST, still carries estrogen's full safety profile—do not assume it is "safer."
Get care right away
- Seek care immediately for chest pain, shortness of breath, leg swelling, sudden severe headache, vision changes, or unexplained bleeding.
When it isn't prescribed
- It is not prescribed with a history of breast or estrogen-sensitive cancer, blood clots, stroke or heart attack, liver disease, unexplained vaginal bleeding, or during pregnancy.
Tell your clinician about every medication and supplement you take.
Questions
Should I start at 0.05 or 0.1?
Your clinician sets the starting dose based on how bothersome your symptoms are. Starting at 0.05 mg allows assessment of tolerability; if symptoms are not controlled, your clinician may increase to 0.1 mg. Some patients start directly at 0.1 mg if symptoms are severe. Your clinician decides.
Is BIEST really bioidentical?
Yes: estriol and estradiol are both bioidentical, meaning their chemical structure matches what your body made. BIEST is a compounded formula mixing these two at a 20:80 ratio. Compounded bioidenticals are not FDA-approved brand products, but the molecules themselves are bioidentical.
Do I need progesterone with BIEST?
If you have a uterus, yes: any estrogen thickens the uterine lining, and a progestogen protects it. Your clinician includes it in your plan. After a hysterectomy, estrogen alone is standard.
Is BIEST better than estradiol alone?
Not necessarily. Both work for menopause symptoms. BIEST appeals to patients seeking a lower dose, a gentler profile, or a compounded approach. Your clinician helps you choose based on symptom severity and tolerability.
Ready to start with BIEST 0.1 mg?
$119/mo · $119 billed every month
- Free shipping on every order
- No membership fee
- Same price at every dose
- HSA and FSA accepted
